Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution.
Target:
ADORA2A
Elisa plates were pre-coated with 0.5 µg/per well purified human ADORA2A full length membrane nanoparticles. Serial diluted anti-Flag monoclonal antibody solutions were added, washed, and incubated with secondary antibody before Elisa reading. From above data, the EC50 for anti-Flag monoclonal antibody binding with ADORA2A full length membrane nanoparticles is 6.796 ng/ml.
FACS analysis of ADORA2A MNPs A. Negative Control 1: ADORA2A full length membrane nanoparticles samples were stained only with Goat anti-mouse lgG 488 secondary antibody. B. Negative Control 2: Control membrane nanoparticles samples were stained with anti-ADORA2A antibody (R&D systems, MAB9497R) at 2 µg/mL, followed by Goat anti-mouse IgG 488 secondary antibody. C. Negative Control 3: ADORA2A full length membrane nanoparticles samples were stained with anti-His antibody (an irrelevant antibody) at 2 µg/mL, followed by Goat anti-mouse IgG 488 secondary antibody. D. ADORA2A full length membrane nanoparticles samples were stained with anti-ADORA2A antibody (R&D systems, MAB9497R) at 2 µg/mL, followed by Goat anti-mouse IgG 488 secondary antibody.
* VAT and and shipping costs not included. Errors and price changes excepted
